日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study

Simlukafusp alfa (FAP-IL2v) 联合阿特珠单抗,加或不加贝伐珠单抗,用于治疗不可切除的转移性肾细胞癌:一项随机、开放标签的 Ib 期研究

Perez-Gracia, Jose Luis; Mellado, Begoña; Hansen, Aaron Richard; Alonso-Gordoa, Teresa; Gomez-Roca, Carlos; Løvendahl Eefsen, Rikke; Negrier, Sylvie; Suárez, Cristina; Lee, Jae-Lyun; Hussain, Arif; Pedrazzoli, Paolo; Moreno, Victor; Rodriguez-Vida, Alejo; Sosman, Jeffrey Alan; Waddell, Tom; Bedke, Jens; Park, Se Hoon; Sznol, Mario; Spychaj, Lukasz; Andersson, Emilia; Julien-Laferriere, Alice; Cheng, Wei-Yi; Watson, Carl; Silva, Ana Patricia; Heichinger, Christian; Staedler, Nicolas; Sleiman, Nassim; Dejardin, David; Boetsch, Christophe; Evers, Stefan; Vardar, Taner; Ardeshir-Tandon, Caroline; Dorado Pérez, Jorge; Charo, Jehad; Keshelava, Nino; Kraxner, Anton; Teichgräber, Volker; Powles, Thomas

Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid Tumors

Cergutuzumab Amunaleukin 与 Atezolizumab 联合治疗癌胚抗原阳性晚期/转移性实体瘤患者

Melero, Ignacio; Tabernero, Josep; Steeghs, Neeltje; Robbrecht, Debbie G J; Peters, Solange; Rizvi, Naiyer A; O'Reilly, Eileen M; Calvo, Emiliano; Eefsen, Rikke L; Leighl, Natasha; Cervantes, Andres; Hafez, Navid; Habigt, Christin; Andersson, Emilia; Dejardin, David; Rossmann, Eva; Martinez Quetglas, Iris; Babitzki, Galina; Duarte, José; Adessi, Celine; Boetsch, Christophe; Evers, Stefan; Charo, Jehad; Teichgräber, Volker; Lassen, Ulrik

Oncology Dose Optimization: Tailored Approaches to Different Molecular Classes

肿瘤剂量优化:针对不同分子类型的个体化方法

Zhu, Jiawen; Schroeder, Amy; Frank, Sabine; Boetsch, Christophe; Jamois, Candice; Kassir, Nastya; Korfi, Koorosh; Punnoose, Elizabeth; Vaze, Anjali; Trask, Peter; Gosai, Pritti; Fridlyand, Jane; Li, Chunze

Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors

新型抗CD25 Treg细胞清除剂RG6292单药及联合阿特珠单抗治疗实体瘤患者的安全性和抗肿瘤活性

Gambardella, Valentina; Ong, Michael; Rodriguez-Ruiz, Maria E; Machiels, Jean-Pascal; Sanmamed, Miguel F; Galvao, Vladimir; Spreafico, Anna; Renouf, Daniel J; Luen, Stephen J; Galot, Rachel; Doger de Spéville, Bernard; Calvo, Emiliano; Naing, Aung; Curdt, Samira; Kolben, Theresa Maria; Rossmann, Eva; Tanos, Tamara; Smart, Kevin; Amann, Maria; Xie, Yuying; Xu, Linxinyu; Gomez Alcaide, Enrique; Städler, Nicolas; Justies, Nicole; Boetsch, Christophe; Karanikas, Vaios; Schnetzler, Gabriel; Rohrberg, Kristoffer S

Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma

一项评估simlukafusp alfa (FAP-IL2v)联合atezolizumab治疗复发性和/或转移性宫颈鳞状细胞癌患者的抗肿瘤活性和安全性的II期研究

Verlingue, Loic; Italiano, Antoine; Prenen, Hans; Guerra Alia, Eva Maria; Tosi, Diego; Perets, Ruth; Lugowska, Iwona; Moiseyenko, Vladimir; Gumus, Mahmut; Arslan, Cagatay; Lindsay, Colin R; Deva, Sanjeev; Taus, Álvaro; Oaknin, Ana; Rottey, Sylvie; Cicin, Irfan; Goksu, Sema Sezgin; Smolin, Alexey; Roselló-Keränen, Susana; Habigt, Christin; Marbach, Daniel; Boetsch, Christophe; Dejardin, David; Sleiman, Nassim; Evers, Stefan; Richard, Muriel; Ardeshir, Caroline; Charo, Jehad; Kraxner, Anton; Teichgräber, Volker; Keshelava, Nino; Dziadziuszko, Rafal

Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid Tumors

Simlukafusp Alfa (FAP-IL2v) 在晚期/转移性实体瘤中的 I 期研究的安全性、药代动力学、药效学和抗肿瘤活性

Steeghs, Neeltje; Gomez-Roca, Carlos; Rohrberg, Kristoffer S; Mau-Sørensen, Morten; Robbrecht, Debbie; Tabernero, Josep; Ahmed, Samreen; Rodríguez-Ruiz, Maria E; Ardeshir, Caroline; Schmid, Daniela; Sleiman, Nassim; Watson, Carl; Piper-Lepoutre, Hanna; Dejardin, David; Evers, Stefan; Boetsch, Christophe; Charo, Jehad; Teichgräber, Volker; Melero, Ignacio

Src/lck inhibitor dasatinib reversibly switches off cytokine release and T cell cytotoxicity following stimulation with T cell bispecific antibodies

Src/lck抑制剂达沙替尼可逆性地关闭T细胞双特异性抗体刺激后的细胞因子释放和T细胞细胞毒性

Gabrielle Leclercq ,Hélène Haegel ,Anneliese Schneider ,Anna Maria Giusti ,Estelle Marrer-Berger ,Christophe Boetsch ,Antje-Christine Walz ,Vesna Pulko ,Johannes Sam ,John Challier ,Cristiano Ferlini ,Alex Odermatt ,Pablo Umaña ,Marina Bacac ,Christian Klein

The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)

McCAVE试验:Vanucizumab联合mFOLFOX-6方案与Bevacizumab联合mFOLFOX-6方案治疗既往未接受治疗的转移性结直肠癌(mCRC)患者的比较

Bendell, Johanna C; Sauri, Tamara; Gracián, Antonio Cubillo; Alvarez, Rafael; López-López, Carlos; García-Alfonso, Pilar; Hussein, Maen; Miron, Maria-Luisa Limon; Cervantes, Andrés; Montagut, Clara; Vivas, Cristina Santos; Bessudo, Alberto; Plezia, Patricia; Moons, Veerle; Andel, Johannes; Bennouna, Jaafar; van der Westhuizen, Andre; Samuel, Leslie; Rossomanno, Simona; Boetsch, Christophe; Lahr, Angelika; Franjkovic, Izolda; Heil, Florian; Lechner, Katharina; Krieter, Oliver; Hurwitz, Herbert

2649. Measles-Containing Vaccination Resulted in a Balanced Cytokine Profile Without Evidence of Immunosuppression in Healthy 12-Month-Old Children

2649. 含麻疹疫苗接种使健康的12月龄儿童体内细胞因子谱达到平衡,且未出现免疫抑制迹象

Lefèvre, Apolline; Parra-Guillen, Zinnia P; Trocóniz, Iñaki F; Boetsch, Christophe; Frances, Nicolas; Gans, Hayley; Wang, Weiqi; Rosenberg-Hasson, Yael; Zerbo, Ousseny; Modaressi, Sharareh; Goddard, Kristin; Lewis, Ned; Bok, Karin; Klein, Nicola

Genetic polymorphisms with erythrocyte traits in malaria endemic areas of Mali

马里疟疾流行区红细胞性状的遗传多态性

Traore, Karim; Konate, Salimata; Thera, Mahamadou A; Niangaly, Amadou; Ba, Alhassane; Niare, Alassane; Arama, Charles; Di Cristofaro, Julie; Baby, Mounirou; Picot, Stephane; Chiaroni, Jacques; Boetsch, Gilles; Doumbo, Ogobara K